Israeli study reveals how well a severe asthma drug works in real patients
NCT ID NCT07218172
Summary
This study looked back at medical records to see how well the drug benralizumab worked for 197 adults with severe asthma in Israel. Researchers tracked patients for up to five years to measure how many asthma flare-ups they experienced before and after starting treatment. The goal was to understand real-world effectiveness of this medication for controlling severe asthma symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Tel Aviv, Israel
Conditions
Explore the condition pages connected to this study.